Utilization of Fourier transform-Raman spectroscopy for the study of pharmaceutical crystal forms.
It is well understood that the solid state physical characterization of a drug substance is necessary for successful development and approval of a pharmaceutical product AAPS [1]. Physical analytical techniques used include: XRD, IR, DSC, TG, and NMR. Recently, Fourier transform (FT) Raman spectroscopy has become a more common technique. Complimentary to IR, FT-Raman can be used to differentiate between different crystal forms of a drug substance. FT-Raman exhibits several advantages over IR and the other physical analytical techniques. Very little sample is required with no preparation (dilution), analysis time is quick, and since water is a weak scatter (Raman spectrum of water contains three low intensity peaks), crystallization studies of drug substances from aqueous solutions can be performed. Additionally, through the use of a variable-temperature accessory, phase diagrams can be determined for crystal systems, leading to further characterization of those systems. This paper introduces the use of FT-Raman spectroscopy for pharmaceutical development activities. Specific examples will be shown for investigations of crystal forms (qualitative and quantitative) and crystallization studies.
Findlay
W P
WP
Bristol-Myers Squibb Pharmaceutical Research Institute, New Brunswick, NJ 08903-0191, USA.
Bugay
D E
DE
D003461:Crystallography / Q000295:instrumentation / Q000379:methods*; D005583:Fourier Analysis; D013055:Spectrophotometry, Infrared; D013059:Spectrum Analysis, Raman / Q000295:instrumentation / Q000379:methods*